A bold prediction regarding AZ's Seroquel

The anonymous blogger at Clinical Psychology and Psychiatry; A Closer Look (catchy name, huh?) predicts that AstraZeneca is prepping a dubious campaign to promote Seroquel, an anti-psychotic agent. "Look for Seroquel to be marketed (stealthily) off-label," s/he says, because AZ has commissioned a range of studies for the drug in various journals, published sponsored editorial, and funded a mental illness advocacy group. AZ already got a warning letter from the FDA for going too far in its Seroquel marketing.